'Living Factories of the Future' Featured in Nature
- Posted on 17 March, 2016
A recent feature in Nature focuses on the various ways industry and academia hope to automate and industrialise Synthetic Biology, including SynbiCITE's upcoming DNA Foundry.
The SynbiCITE Foundry, which will be first Synthetic Biology DNA Foundry available for commercial use in Europe, will provide automated end-to-end design, construction and validation of synthetic biologic components using a suite of state-of-the-art robotic equipment.
The Foundry will provide synthetic biology manufacturing capabilities and training to organisations with innovative ways of using synthetic biology but without the facilities to develop them further.
Share this article:
People also read
Measurement for Recovery
Measurement for RecoveryNew programme to help boost competitiveness and resilience of UK industry, led by the National Physical Laboratory (NPL)NPL is...
SynbiTECH2020 is going virtual!
SynbiTECH 2020 is now entirely virtual to ensure everyone can join us to discuss the latest transformations in synthetic biology and its contribution to the global bioeconomy.
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...